Ultragenyx close to learning whether gene therapy gamble will pay off

Ultragenyx close to learning whether gene therapy gamble will pay off

Source: 
Biopharma Dive
snippet: 

Two therapies acquired in a 2017 buyout of Dimension are poised to enter late-stage testing, if results due soon look good.